The Significance of Gene Polymorphism in Dyslipidemia Population for Medication Usage Application

The Significance of Gene Polymorphism in Dyslipidemia Population for Medication Usage Application

JIA Chundi, SHAO Sujun, LIU Na, YANG Tianyin, LIU Tianci, LI Tao, WANG Ying, ZHANG Man

PDF(1046 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1046 KB)

Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (10) : 1675-1681. DOI: 10.11748/bjmy.issn.1006-1703.2022.10.011

Clinical Investigation

The Significance of Gene Polymorphism in Dyslipidemia Population for Medication Usage Application

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(10): 1675-1681 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.10.011

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1046 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉